Dadra and Nagar Haveli Chandigarh Himachal Pradesh Andaman and Nicobar Islands Uttarakhand Daman and Diu Lakshadweep Gujarat South India North India East India Andhra Pradesh Assam Arunachal Pradesh Nagaland Goa Haryana Jammu and Kashmir Jharkhand Karnataka Kerala Madhya Pradesh Mizoram Meghalaya Manipur Punjab Pondicherry Rajasthan Sikkim Tamil Nadu Tripura West Bengal Bihar Odisha Chhattisgarh Maharashtra Delhi Uttar Pradesh Telangana Central India West India All India
Product Description
TAFFIC is indicated for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for Hiv